LUXTURNA

LUXTURNA is the first prescription gene therapy product to help improve functional vision in patients with an inherited retinal disease (IRD) due to a mutation in their RPE65 gene. It is a one-time gene therapy that has the potential to restore the visual cycle-the process that allows you to see.

Also known as: Spark Therapeutics, Spark Therapeutics, Inc.